CHJTF — Stock activity · TradeandTellCHJT
CHJTF
$1.07+$0.09 (+9.26%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.94 – $1.39
29% from low
Held by traders on TradeandTell
No one on the platform currently holds CHJTF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CHJTF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 51.40% ($0.55/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-06-26 | $0.1500 | 2026-07-15 |
| 2025-10-21 | $0.1400 | 2025-11-18 |
| 2025-06-06 | $0.1000 | 2025-07-18 |
| 2024-11-04 | $0.1600 | 2024-11-20 |
| 2024-06-04 | $0.1400 | 2024-06-26 |
| 2023-09-08 | $0.1400 | 2023-10-12 |
Recent trades on TradeandTell
No one on the platform has traded CHJTF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $36.7B | +18.3% | $0.76 | $0.58–$1.01 | 1.4× | 1 |
| 2027 | $36.1B | -1.6% | $0.62 | $0.47–$0.82 | 1.7× | 1 |
| 2028 | $38.7B | +7.2% | $0.67 | $0.51–$0.89 | 1.6× | 1 |
| 2029 | $45.9B | +18.6% | $0.96 | $0.73–$1.27 | 1.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 2 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2023-03-22 | $0.12 | $0.14 | +16.7% |
| 2022-11-22 | $0.12 | $0.13 | +8.3% |
| 2022-05-25 | $0.16 | $0.12 | -25.0% |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| CHJTFCSPC Pharmaceutical Group Limited | $1.07 | +0.00% | $12.2B | — |
| ALBBYAlibaba Health Information Technology Limited | $8.88 | +0.34% | $7.2B | — |
| BDUUYBangkok Dusit Medical Services Public Company Limited | $23.30 | +0.00% | $9.3B | — |
| BIOVFSwedish Orphan Biovitrum AB (publ) | $48.20 | +0.00% | $16.7B | — |
| ERFSFEurofins Scientific SE |
| GIFLFGrifols, S.A. | $11.76 | +0.00% | $8.0B | — |
| OCPNFOlympus Corporation | $13.20 | +0.00% | $14.5B | — |
Source: Financial Modeling Prep · peers by sector/industry